Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients

Table 1

Summary of individual studies on prevalence of anaemia in IBD, retrieved from recent literature reviews.

Author	Year	Country	Patients ()	Prevalence of anaemia (%)
				IBD	CD	UC
Koutroubakis et al.	2016	USA	1,821	50.1	53.3 (574/1,077)	44.7 (333/744)
Hoivik et al.	2014	Norway	756	29.1	48.8 (116/237)	20.2 (104/519)
Sjoberg et al.	2014	Sweden	749	30	42 (107/254	24 (119/495)
Toruner et al.	2014	Turkey	398	45.11	24 (45/186)	22 (47/212)
Rejler et al.	2012	Sweden	485	6	9	5
Bager et al.	2011	Denmark, Norway, Sweden	429	17	23.6 (60/254)	7.4 (13/175)
Bergamaschi et al.	2010	Italy	263	36.96	43 (71/165)	34 (33/98)
Blumenstein et al.	2011/2008	Germany	636	18.87	17 (57/336)	21 (63/300)
Goodhand et al.	2011	UK	124	40	48	45
Oustamanolakis et al.	2011	Greece	100	42	42 (20/48)	41 (21/51)
Romberg-Camps et al.	2010	Netherlands	707	9.2	11.5	7.3
Voegtlin et al.	2010	Switzerland	241	19.92	17 (23/137)	24 (25/104)
De la Morena and Gisbert	2009	Spain	253	24.11	32 (43/136)	15 (18/117)
Vijverman et al.	2006	Belgium	170	24.7	/	/
Ebinger et al.	2004	Germany	599	4.8	3.2 (13/390)	6.2 (13/209)
Ershler et al.	2005	USA	7200	13	/	/
Lakatos et al.	2003	Hungary	254	26.5	35.8	25
Revel-Vilke et al.	2000	Israel	63	41.3	/	/
Schreiber et al.	1996	Germany	676	31.7	26 (88/334)	37 (126/342)
Gasche et al.	1994	Austria	49	/	33 (16/49)	/
Horina et al.	1993	Austria	85	33	/	/

Modified from Filmann et al. [23], Stein et al. [21], and Kulnigg and Gasche [22].